NDAORALTABLET
Approved
Dec 2015
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
Post-Authorisation Safety Study of Lesinurad
Started Jan 2021
0GoutHyperuricemia
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
Started Jul 2017
Loss of Exclusivity
LOE Date
Feb 29, 2032
72 months away
Patent Expiry
Feb 29, 2032
External Resources